Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB -455 G/A polymorphism

Atherosclerosis

Volumn 191, Issue 2, 2007, Pages 369-376

  Maumus, Sandy ^a   Marie, Bérangère ^a   Vincent Viry, Monique ^b   Siest, Gérard ^a,b   Visvikis Siest, Sophie ^a  

^a INSERM   (France)

^b Centre de Medecine Preventive   (France)

Author keywords

Adhesion molecules; Cardiovascular disease; FGB gene; Genetic polymorphism; Insulin; Metabolic syndrome; Type 2 diabetes

Indexed keywords

FIBRINOGEN; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIUM; ENVIRONMENTAL FACTOR; ENZYME IMMUNOASSAY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HYPOTHESIS; MALE; METABOLIC DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT;

ADENINE; ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; FIBRINOGEN; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HOMEOSTASIS; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; RISK FACTORS;

EID: 33947124608     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.04.003     Document Type: Article

References (37)

1. Stern M.P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44 (1995) 369-374
2. Undlien D.E., and Berg J.P. Common variants in the regulatory region of the insulin gene are associated with fasting plasma insulin levels in juvenile obesity. Eur J Endocrinol 144 (2001) 457-459
3. Urhammer S.A., Fridberg M., Hansen T., et al. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 46 (1997) 912-916
4. Duggirala R., Stern M.P., Mitchell B.D., et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 59 (1996) 694-703
5. Mitchell B.D., Cole S.A., Hsueh W.C., et al. Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes 49 (2000) 513-516
6. Feng Y., Niu T., Xu X., et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 51 (2002) 1986-1988
7. Cong N.D., Hamaguchi K., Saikawa T., Hara M., and Sakata T. The I/D polymorphism of angiotensin-converting enzyme gene but not the angiotensinogen gene is associated with insulin response to oral glucose in Japanese. Proc Soc Exp Biol Med 220 (1999) 46-51
8. Russo G.T., Meigs J.B., Cupples L.A., et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158 (2001) 173-181
9. Perez-Jimenez F., Lopez-Miranda J., Gomez P., et al. The SstI polymorphism of the apo C-III gene is associated with insulin sensitivity in young men. Diabetologia 45 (2002) 1196-1200
10. van't Hooft F.M., von Bahr S.J., Silveira A., et al. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19 (1999) 3063-3070
11. Thomas A.E., Green F.R., Lamlum H., and Humphries S.E. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers. J Med Genet 32 (1995) 585-589
12. Carter A.M., Mansfield M.W., Stickland M.H., and Grant P.J. Beta-fibrinogen gene -455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM. Diab Care 19 (1996) 1265-1268
13. Kessler C., Spitzer C., Stauske D., et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 17 (1997) 2880-2884
14. Humphries S.E., Ye S., Talmud P., et al. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 15 (1995) 96-104
15. de Maat M.P., Kastelein J.J., Jukema J.W., et al. -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 18 (1998) 265-271
16. Imperatore G., Riccardi G., Iovine C., Rivellese A.A., and Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diab Care 21 (1998) 649-654
17. Siest G., Visvikis S., Herbeth B., et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 36 (1998) 35-42
18. Mansour-Chemaly M., Haddy N., Siest G., and Visvikis S. Family studies: their role in the evaluation of genetic cardiovascular risk factors. Clin Chem Lab Med 40 (2002) 1085-1096
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Ponthieux A., Herbeth B., Droesch S., et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 172 (2004) 299-308
21. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
22. Cheng S., Pallaud C., Grow M.A., et al. A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 36 (1998) 561-566
23. Hoppe C., Klitz W., Cheng S., et al., CSSCD Investigators. Gene interactions and stroke risk in children with sickle cell anemia. Blood 103 (2004) 2391-2396
24. Altshuler D., Hirschhorn J.N., Klannemark M., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
25. Luan J., Browne P.O., Harding A.H., et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50 (2001) 686-689
26. Mancini F.P., Vaccaro O., Sabatino L., et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 48 (1999) 1466-1468
27. Meirhaeghe A., Fajas L., and Helbecque N. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 24 (2000) 195-199
28. Kamath S., and Lip G.Y. Fibrinogen: biochemistry, epidemiology and determinants. QJM 96 (2003) 711-729
29. Dunn E.J., and Ariens R.A. Fibrinogen and fibrin clot structure in diabetes. Herz 29 (2004) 470-479
30. Green F., Hamsten A., Blomback M., and Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infection and healthy controls from Sweden. Thromb Haemost 70 (1993) 915-920
31. Behague I., Poirier O., Nicaud V., et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 93 (1996) 440-449
32. Scarabin P.Y., Bara L., Ricard S., et al. Genetic variation at the β-fibrinogen locus in relation to fibrinogen concentrations and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 13 (1993) 886-891
33. Smith G.D., Harbord R., Milton J., Ebrahim S., and Sterne J.A. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb Vasc Biol 25 (2005) 2228-2233
34. Reinhart W.H. Fibrinogen-marker or mediator of vascular disease?. Vasc Med 8 (2003) 211-216
35. Pallaud C., Sass C., Zannad F., Siest G., and Visvikis S. APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 59 (2001) 316-324
36. Hsueh W.A., Lyon C.J., and Quinones M.J. Insulin resistance and the endothelium. Am J Med 117 (2004) 109-117
37. Rabe T., and Runnebaum B. Update on oral contraception. Eur J Obstet Gynecol Reprod Biol 49 (1993) 10-12